Our ambition is to become the world's preferred partner in the management of iron deficiency and iron deficiency anaemia. We strive to achieve this partnership by simplifying the treatment, spearheading the improvement of patient safety, and driving the expanded use of high-dose intravenous iron across therapy fields. Beyond iron deficiency, we are expanding our research into oncology care to improve outcomes for patients undergoing chemotherapy.
Explore our products
Monoferric®
Monoferric® - ferric derisomaltose
Advancing scientific knowledge
We conduct clinical research, including large randomised trials, to expand understanding of iron metabolism and anaemia. Our studies contribute to the global evidence base for intravenous iron therapies.
A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
